With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Mechanisms of Oncogenic Transformation by TLX1/HOX11||University of Michigan / Mark Chiang||Young Investigator Grants||2011||Michigan|
|Phase I and II Clinical Research Program Infrastructure Award||University of Minnesota / Brenda Weigel, MD, MSc||Phase I/II Infrastructure Grants||2011||Minnesota|
|The Role of Mxi1 in the Modulation N-Myc Function in Neuroblastoma||Duke University / Michael Armstrong||Young Investigator Grants||2011||North Carolina|
|Clinical Development of RNA Nanoparticle Vaccines Targeting Recurrent Pediatric Brain Cancers||Duke University / Duane Mitchell, MD, PhD||Innovation Grants||2011||North Carolina|
|The role of primary cilia in rhabdomyosarcoma||New York University School of Medicine / Brian Dynlacht, PhD||Innovation Grants||2011||New York|
|SickKids MIBG and Phase I Leukemia Programs||Hospital for Sick Children / James Whitlock, MD||Phase I/II Infrastructure Grants||2011||Ontario|
|BH3 Profiling to define therapy resistance classes in neuroblastoma||Children's Hospital of Philadelphia / Michael Hogarty, MD||Innovation Grants||2011||Pennsylvania|
|Children's Hospital of Pittsburgh of UPMC Phase 1-2 Infrastructure Support Grant||University of Pittsburgh / A. Kim Ritchey||Phase I/II Infrastructure Grants||2011||Pennsylvania|
|Targeting polycomb-mediated epigenetic silencing in T cell acute lymphoblastic leukemia||Vanderbilt University Medical Center / Emmanuel Volanakis||Young Investigator Grants||2011||Tennessee|
|Strategies for Epigenetically Reprogramming Neuroblastoma Cancer Stem Cells||Baylor College of Medicine / Jason Shohet, MD, PhD||Innovation Grants||2011||Texas|